FRI0185 In rheumatoid arthritis patients with stable low disease activity on methotrexate plus etanercept, continuation of etanercept at 50 mg or 25 mg weekly are both clinically superior to discontinuation: results from a randomized, 3-arm, double-blind study

Abstract

BackgroundThe efficacy of etanercept (ETN) plus methotrexate (MTX) in rheumatoid arthritis (RA) is well-established; long-term trials have shown that continued treatment maintains clinical response and prevents radiographic damage.ObjectivesTo study whether...